Bruker

Company Overview

Bruker develops, manufactures, and distributes scientific instruments and analytical and diagnostic tools that enable users to investigate materials and life forms at the microscopic, molecular, and cellular levels. Through its high-performance platforms, including TimsTOF Pro, MALDI-TOF MS, FT-ICR-MS, and NMR spectroscopy systems, Bruker facilitates the discovery, validation, and characterization of biomarkers in therapeutic areas, including oncology, neurology, cardiology, and infectious diseases.

The company operates its business under four reportable segments namely: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company has direct sales representatives in China, Japan, Europe, North America, and other Asia-Pacific countries.

Financial Highlights (FY 2025)

Company's Business Segments

• BSI BioSpin : This segment includes Bruker Magnetic Resonance, Applied Industrial and Clinical, Preclinical Imaging and Service, Lifecycle Support, and Integrated Data Solution Divisions.
• BSI CALID : This segment includes the Bruker Life Sciences Mass Spectrometry, Bruker Applied Mass Spectrometry, Bruker Microbiology and Diagnostics, and Bruker Optics Divisions.
• BSI Nano : This segment includes Bruker AXS, Bruker Nano Analytics, Bruker Nano Surfaces and Metrology divisions, Consolidated Fluorescence Microscopy, Canopy Biosciences and Acuity Business Units.
• BEST : This segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors used in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications.